Predictors of patient and graft survival following liver transplantation for hepatitis C
Michael Charlton, Eric Seaberg, Russell Wiesner, James Everhart, Rowen Zetterman, John Lake, Katherine Detre, Jay Hoofnagle – 30 December 2003 – End‐stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal.